Monkey_NN Rotavirus_NP Binding_NP to_TO alpha2beta1_JJ Integrin_NP Requires_NP the_DT alpha2_JJ I_NP Domain_NP and_CC Is_VBZ Facilitated_JJ by_IN the_DT Homologous_JJ beta1_JJ Subunit_NP Rotaviruses_NNS utilize_VBP integrins_NNS during_IN virus-cell_NN interactions_NNS that_WDT lead_VBP to_TO infection_NN ._SENT Cell_NN binding_NN and_CC infection_NN by_IN simian_JJ rotavirus_NN SA11_NP were_VBD inhibited_VBN by_IN antibodies_NNS (_( Abs_NP )_) to_TO the_DT inserted_JJ (_( I_PP )_) domain_NN of_IN the_DT alpha2_JJ integrin_NN subunit_NN ._SENT To_TO determine_VB directly_RB which_WDT integrins_NNS or_CC other_JJ proteins_NNS bind_NN rotaviruses_NNS ,_, cell_NN surface_NN proteins_NNS precipitated_VBD by_IN rotaviruses_NNS were_VBD compared_VBN with_IN those_DT precipitated_VBN by_IN anti-alpha2beta1_JJ Abs_NP ._SENT Two_CD proteins_NNS precipitated_VBN by_IN SA11_NP and_CC rhesus_NN rotavirus_NN RRV_NP from_IN MA104_NP and_CC Caco-2_NP cells_NNS migrated_VBD indistinguishably_RB from_IN alpha2beta1_JJ integrin_NN ,_, and_CC SA11_NP precipitated_VBD beta1_JJ from_IN alpha2beta1-transfected_JJ CHO_NP cells_NNS ._SENT These_DT viruses_NNS specifically_RB precipitated_VBD two_CD MA104_NP cell_NN proteins_NNS only_RB ,_, but_CC an_DT additional_JJ 160-_CD to_TO 165-kDa_NP protein_NN was_VBD precipitated_VBN by_IN SA11_NP from_IN Caco-2_NP cells_NNS ._SENT The_DT role_NN of_IN the_DT alpha2_JJ I_CD domain_NN in_IN rotavirus_NN binding_NN ,_, infection_NN ,_, and_CC growth_NN was_VBD examined_VBN using_VBG CHO_NP cell_NN lines_NNS expressing_VBG wild-type_NN or_CC mutated_VBN human_JJ alpha2_NN or_CC alpha2beta1_JJ ._SENT Infectious_JJ SA11_NP and_CC RRV_NP ,_, but_CC not_RB human_JJ rotavirus_NN Wa_NP ,_, specifically_RB bound_VBN CHO_NP cell-expressed_JJ human_JJ alpha2beta1_NN and_CC ,_, to_TO a_DT lesser_JJR extent_NN ,_, human_JJ alpha2_NN combined_VBN with_IN hamster_NN beta1_NN ._SENT Binding_VBG was_VBD inhibited_VBN by_IN anti-alpha2_JJ I_NP domain_NN monoclonal_NN Abs_NP (_( MAbs_NP )_) ,_, but_CC not_RB by_IN non-I_NP domain_NN MAbs_NNS to_TO alpha2_NN ,_, and_CC required_VBD the_DT presence_NN of_IN the_DT alpha2_JJ I_NP domain_NN ._SENT Amino_NN acid_NN residues_NNS 151_CD ,_, 221_CD ,_, and_CC 254_CD in_IN the_DT metal_NN ion-dependent_JJ adhesion_NN site_NN of_IN the_DT alpha2_JJ I_NP domain_NN that_WDT are_VBP necessary_JJ for_IN type_NN I_CD collagen_NN binding_JJ to_TO alpha2beta1_JJ were_VBD not_RB essential_JJ for_IN rotavirus_NN binding_NN ._SENT Rotavirus-alpha2beta1_JJ binding_NN led_VBN to_TO increased_VBN virus_NN infection_NN and_CC RRV_NP growth_NN ._SENT SA11_NP and_CC RRV_NP require_VBP the_DT alpha2_JJ I_CD domain_NN for_IN binding_VBG to_TO alpha2beta1_JJ ,_, and_CC their_PP$ binding_NN to_TO this_DT integrin_NN is_VBZ distinguishable_JJ from_IN that_IN of_IN collagen_NN ._SENT Virus_NN attachment_NN and_CC entry_NN into_IN host_NN cells_NNS are_VBP multistep_NN processes_NNS that_WDT influence_VBP cellular_JJ tropism_NN and_CC can_MD involve_VB sequential_JJ recognition_NN of_IN multiple_JJ receptors_NNS and_CC coreceptors_NNS ._SENT Rotaviruses_NP ,_, a_DT genus_NN within_IN the_DT Reoviridae_NP family_NN ,_, cause_VB severe_JJ gastroenteritis_NN following_VBG infection_NN of_IN intestinal_JJ enterocytes_NNS ._SENT The_DT virus_NN spike_NN protein_NN ,_, VP4_NP ,_, which_WDT is_VBZ a_DT major_JJ determinant_NN of_IN tropism_NN and_CC receptor_NN binding_NN ,_, is_VBZ proteolytically_RB cleaved_VBN by_IN trypsin_NN into_IN VP5*_NP and_CC VP8*_NP ,_, which_WDT increases_VBZ the_DT virus_NN infectivity_NN and_CC internalization_NN rate_NN ._SENT Several_JJ glycoconjugates_NNS have_VBP been_VBN implicated_VBN in_IN rotavirus_NN attachment_NN ._SENT Although_IN a_DT minority_NN of_IN animal_JJ rotaviruses_NNS ,_, including_VBG simian_JJ strains_NNS SA11_NP and_CC RRV_NP ,_, can_MD utilize_VB terminal_JJ sialic_JJ acids_NNS (_( SA_NP )_) as_IN receptors_NNS ,_, SA_NP are_VBP not_RB essential_JJ for_IN infectivity_NN ._SENT SA-using_VBG porcine_JJ rotaviruses_NNS OSU_NP and_CC CRW-8_NP appear_VBP to_TO use_VB ganglioside-_NN and_CC glycolipid-based_JJ receptors_NNS ,_, respectively_RB ._SENT RRV_NP binds_VBZ sialosides_NNS with_IN low_JJ affinity_NN via_IN a_DT galectin-like_JJ region_NN in_IN VP8*_NP ._SENT In_IN searching_VBG for_IN rotavirus_NN receptors_NNS ,_, Coulson_NP et_FW al._FW found_VBD that_IN VP4_NP and_CC rotavirus_NP outer_JJ capsid_NN protein_NN VP7_JJ contain_VBP sequences_NNS corresponding_JJ to_TO integrin_NN recognition_NN sites_NNS ._SENT Integrins_NNS are_VBP alpha/beta_NN heterodimeric_JJ ,_, transmembrane_JJ glycoproteins_NNS important_JJ for_IN cell_NN surface_NN adhesion_NN and_CC signaling_VBG ._SENT The_DT RDGE_NP sequence_NN in_IN VP4_NP at_IN amino_NN acids_NNS (_( aa_NN )_) 307_CD to_TO 310_CD corresponds_VBZ to_TO the_DT putative_JJ alpha2beta1_JJ integrin_NN recognition_NN sequence_NN DGE(A)_NP in_IN type_NN I_CD collagen_NN ._SENT VP7_JJ contains_VBZ the_DT alphaxbeta2_JJ integrin_NN ligand_NN sequence_NN ,_, GPR_NP ,_, and_CC several_JJ potential_JJ alpha4beta1_JJ integrin_NN ligand_NN sites_NNS ._SENT Monoclonal_NP antibodies_NNS (_( MAbs_NP )_) to_TO alpha2beta1_JJ and_CC alphaxbeta2_JJ ,_, and_CC peptides_NNS containing_VBG these_DT integrin_NN ligand_NN sequences_NNS ,_, inhibited_VBD SA11_NP and_CC human_JJ rotavirus_NN RV-5_NP infection_NN of_IN MA104_NP and_CC Caco-2_NP cells_NNS ,_, which_WDT were_VBD shown_VBN to_TO express_VB alpha2beta1_JJ and_CC alphaxbeta2_JJ integrins_NNS ,_, by_IN 30_CD to_TO 90_CD %_NN ._SENT As_IN Caco-2_NP cells_NNS model_NN small_JJ intestinal_JJ epithelial_JJ cells_NNS ,_, this_DT suggested_VBD that_IN SA11_NP could_MD use_VB alpha2beta1_JJ for_IN infection_NN of_IN intestinal_JJ cells_NNS ._SENT Surface_NN expression_NN of_IN alpha2beta1_NN correlated_VBN with_IN susceptibility_NN of_IN MA104_NP ,_, Caco-2_NP ,_, RD_NP ,_, K562_NP ,_, and_CC COS-7_JJ cells_NNS to_TO SA11_JJ infection_NN ._SENT SA11_NP showed_VBD increased_VBN levels_NNS of_IN binding_NN and_CC growth_NN in_IN alpha2beta1-_NN and_CC alpha4beta1-transfected_JJ K562_NP cells_NNS ,_, which_WDT were_VBD specifically_RB blocked_VBN by_IN anti-alpha2_NP and_CC anti-alpha4_NP MAbs_NP ,_, respectively_RB ._SENT From_IN these_DT data_NNS ,_, it_PP was_VBD concluded_VBN that_IN alpha2beta1_JJ and_CC alpha4beta1_JJ can_MD act_VB as_IN SA11_JJ receptors_NNS ._SENT It_PP has_VBZ been_VBN proposed_VBN that_IN rotavirus-cell_NN binding_NN can_MD involve_VB initial_JJ carbohydrate_NN recognition_NN followed_VBN by_IN integrin_NN interaction_NN ._SENT More_RBR recently_RB ,_, the_DT neuraminidase-resistant_JJ RRV_NP mutant_JJ nar3_NN was_VBD shown_VBN to_TO bind_VB alpha2beta1_JJ ._SENT Another_DT integrin_NN ,_, alphavbeta3_NN ,_, has_VBZ been_VBN shown_VBN to_TO promote_VB infection_NN by_IN RRV_NP ,_, nar3_NN ,_, and_CC human_JJ rotavirus_NN Wa_NP ._SENT Rotavirus_NNS binding_VBG to_TO alphavbeta3_NN was_VBD not_RB detected_VBN ._SENT It_PP has_VBZ been_VBN confirmed_VBN that_DT infection_NN by_IN SA11_NP and_CC RRV_NP is_VBZ inhibited_VBN by_IN anti-alpha2_NP MAbs_NP and_CC DGE-containing_NP peptides_NNS ._SENT The_DT infectivity_NN of_IN several_JJ other_JJ rotaviruses_NNS ,_, including_VBG Wa_NP ,_, was_VBD also_RB inhibited_VBN by_IN anti-alpha2_JJ MAbs_NNS ._SENT However_RB ,_, binding_VBG of_IN RRV_NP to_TO alpha2beta1_NN could_MD not_RB be_VB detected_VBN in_IN two_CD studies_NNS ,_, and_CC evidence_NN that_IN SA11_NP ,_, Wa_NP ,_, and_CC other_JJ rotavirus_NN strains_NNS bind_NN to_TO alpha2beta1_JJ was_VBD not_RB found_VBN by_IN one_CD of_IN these_DT groups_NNS ._SENT A_DT summary_NN of_IN the_DT previously_RB published_VBN studies_NNS of_IN anti-integrin_NP MAb_NP blockade_NN of_IN rotavirus-cell_NN binding_NN and_CC infection_NN is_VBZ presented_VBN in_IN Table_NP ._SENT To_TO directly_RB investigate_VB the_DT cell_NN surface_NN proteins_NNS bound_VBN by_IN rotaviruses_NNS ,_, we_PP developed_VBD a_DT novel_JJ virus_NN immunoprecipitation_NN technique_NN designed_VBN to_TO maintain_VB integrin_NN ligand-binding_NN function_NN ,_, which_WDT included_VBD divalent_JJ cations_NNS ,_, maintenance_NN of_IN the_DT alpha/beta_NN subunit_NN association_NN ,_, and_CC preservation_NN of_IN disulfide_NN bonds_NNS ._SENT Using_VBG this_DT method_NN ,_, we_PP show_VBP here_RB that_IN SA11_NP precipitates_NNS surface_VBP beta1_JJ from_IN alpha2beta1-transfected_JJ Chinese_JJ hamster_NN ovary_NN (_( CHO_NP )_) cells_NNS ,_, SA11_NP and_CC RRV_NP precipitate_VBP two_CD surface_NN proteins_NNS with_IN the_DT characteristics_NNS of_IN alpha2_JJ and_CC beta1_JJ from_IN MA104_NP cells_NNS ,_, and_CC SA11_NP precipitates_VBZ these_DT two_CD proteins_NNS and_CC a_DT third_JJ protein_NN of_IN 160_CD to_TO 165_CD kDa_NN from_IN Caco-2_JJ cells_NNS ._SENT As_IN SA11_JJ binding_NN and_CC infectivity_NN were_VBD inhibited_VBN by_IN anti-alpha2_JJ MAbs_NNS which_WDT also_RB block_VBP alpha2beta1_JJ binding_NN to_TO collagen_NN and_CC as_IN infectivity_NN was_VBD inhibited_VBN with_IN the_DT collagen-derived_JJ peptide_NN sequence_NN DGE_NN ,_, it_PP was_VBD proposed_VBN that_IN SA11_NP might_MD bind_VB alpha2beta1_JJ similarly_RB to_TO collagen_NN ._SENT Within_IN alpha2beta1_NN ,_, the_DT upper_JJ surface_NN of_IN the_DT inserted_JJ (_( I_PP )_) domain_NN of_IN alpha2_NN ,_, including_VBG the_DT metal_NN ion-dependent_JJ adhesion_NN site_NN (_( MIDAS_NP )_) ,_, contains_VBZ all_PDT the_DT components_NNS required_VBN for_IN collagen_NN binding_NN ._SENT Within_IN the_DT alpha2_JJ MIDAS_NP ,_, aa_NN residues_NNS 151_CD ,_, 221_CD ,_, and_CC 254_CD are_VBP essential_JJ for_IN alpha2beta1_JJ binding_NN to_TO collagen_NN ._SENT Echovirus_NN type_NN 1_CD binds_NNS to_TO alpha2beta1_JJ ,_, its_PP$ cellular_JJ receptor_NN ,_, via_IN a_DT region_NN of_IN the_DT alpha2_JJ I_NP domain_NN partially_RB overlapping_VBG that_IN bound_VBN by_IN a_DT collagen-derived_JJ ,_, triple-helical_JJ peptide_NN ._SENT However_RB ,_, in_IN contrast_NN to_TO collagen_NN ,_, the_DT MIDAS_NP is_VBZ not_RB involved_VBN in_IN echovirus_NN binding_VBG to_TO alpha2beta1_NN ._SENT It_PP has_VBZ been_VBN reported_VBN that_IN the_DT infectivity_NN of_IN RRV_NP and_CC other_JJ rotaviruses_NNS was_VBD increased_VBN in_IN CHO_NP cells_NNS following_VBG transfection_NN with_IN human_JJ alpha2_NN or_CC alpha2beta1_JJ but_CC that_IN the_DT level_NN of_IN virus_NN binding_NN was_VBD not_RB altered_VBN ._SENT From_IN this_DT study_NN ,_, it_PP was_VBD concluded_VBN that_IN an_DT anti-alpha2_NP MAb_NP inhibited_VBD the_DT increased_VBN infectivity_NN but_CC had_VBD no_DT effect_NN on_IN virus_NN binding_VBG to_TO the_DT alpha2-_NN or_CC alpha2beta1-transfected_JJ CHO_NP cells_NNS ._SENT To_TO analyze_VB the_DT roles_NNS of_IN human_JJ alpha2_NN ,_, beta1_JJ ,_, the_DT alpha2_JJ I_NP domain_NN ,_, and_CC the_DT alpha2_JJ MIDAS_NP in_IN rotavirus_NN recognition_NN of_IN alpha2beta1_JJ ,_, we_PP utilized_VBD integrin-transfected_JJ CHO_NP cell_NN lines_NNS which_WDT had_VBD been_VBN used_VBN previously_RB to_TO map_VB the_DT human_JJ alpha2beta1_JJ regions_NNS involved_VBN in_IN collagen_NN binding_NN ._SENT We_PP found_VBD that_IN infectious_JJ SA11_NP and_CC RRV_NP specifically_RB bound_VBN CHO_NP cell-expressed_JJ human_JJ alpha2beta1_JJ integrin_NN and_CC ,_, to_TO a_DT lesser_JJR extent_NN ,_, human_JJ alpha2_NN combined_VBN with_IN hamster_NN beta1_NN ._SENT This_DT binding_NN was_VBD inhibited_VBN by_IN anti-alpha2_JJ I_NP domain_NN MAbs_NNS but_CC not_RB by_IN non-I_NP domain_NN MAbs_NNS to_TO alpha2_NN ._SENT It_PP required_VBD the_DT presence_NN of_IN the_DT alpha2_JJ I_NP domain_NN but_CC not_RB MIDAS_NP residues_NNS 151_CD ,_, 221_CD ,_, and_CC 254_CD ._SENT Our_PP$ experiments_NNS showed_VBD that_IN the_DT infectivity_NN of_IN SA11_NP and_CC RRV_NP and_CC the_DT replication_NN of_IN RRV_NP were_VBD increased_VBN following_VBG virus_NN binding_VBG to_TO alpha2beta1_JJ integrin_NN on_IN CHO_NP cells_NNS ._SENT Cell_NN lines_NNS ,_, viruses_NNS ,_, and_CC antibodies_NNS ._SENT |_SYM MA104_NP and_CC Caco-2_NP cells_NNS were_VBD propagated_VBN as_IN described_VBN before_IN ._SENT The_DT derivation_NN of_IN CHO_NP K1_NP cell_NN transfectants_NNS expressing_VBG human_JJ alpha2_NN (_( CHO_NP alpha2_NP )_) ,_, the_DT human_JJ alpha2_NN and_CC beta1_JJ integrin_NN subunits_NN (_( CHO_NP alpha2beta1_NP )_) ,_, the_DT human_JJ alpha2_JJ subunit_NN with_IN alanine-swapping_JJ mutations_NNS (_( CHO_NP alpha2_NP D151A_NP ,_, CHO_NP alpha2_NP D254A_NP ,_, and_CC CHO_NP alpha2_NP T221A_NP )_) ,_, the_DT human_JJ beta1_JJ and_CC alpha2_JJ subunits_NN with_IN an_DT alpha2_JJ I_NP domain_NN deletion_NN (_( CHO_NP alpha2delIbeta1_NP )_) ,_, and_CC the_DT PBJ-1_JJ empty_JJ vector_NN (_( CHO_NP K1_NP PBJ-1_NP )_) has_VBZ been_VBN described_VBN previously_RB (_( ,_, ,_, ,_, -_: )_) ._SENT Cultivation_NN of_IN CHO_NP cell_NN lines_NNS was_VBD performed_VBN as_RB for_IN MA104_JJ cells_NNS ,_, except_IN that_DT G418_NP sulfate_NN (_( Gibco_NP BRL_NP ,_, Grand_NP Island_NP ,_, N.Y._NP )_) at_IN 0.1_CD to_TO 1_CD mg/ml_NN was_VBD included_VBN in_IN transfectant_JJ growth_NN medium_NN ._SENT Integrin_NN expression_NN on_IN CHO_NP cell_NN lines_NNS was_VBD monitored_VBN regularly_RB by_IN flow_NN cytometry_NN as_RB described_VBD previously_RB ._SENT Rotaviruses_NP SA11_NP ,_, RRV_NP ,_, and_CC Wa_NP were_VBD grown_VBN in_IN MA104_NP cells_NNS ._SENT For_IN purification_NN by_IN glycerol_NN gradient_JJ ultracentrifugation_NN ,_, virus_NN was_VBD grown_VBN in_IN cell_NN cultures_NNS on_IN beads_NNS ._SENT Rabbit_NN antisera_NN to_TO SA11_NP (_( anti-SA11_JJ )_) and_CC RRV_NP (_( anti-RRV_NP )_) were_VBD produced_VBN as_IN described_VBN before_IN and_CC showed_VBD fluorescent_JJ focus_NN reduction_NN neutralization_NN assay_NN titers_NNS of_IN 1:100,000_CD and_CC 1:80,000_CD ,_, respectively_RB ,_, against_IN homologous_JJ virus_NN ._SENT According_VBG to_TO the_DT results_NNS of_IN enzyme_NN immunoassays_NNS (_( EIA_NP )_) performed_VBD as_RB described_VBN previously_RB ,_, preimmune_JJ rabbit_NN sera_NN (_( control_NN Ab_NP )_) showed_VBD reciprocal_JJ titers_NNS of_IN <100_NN against_IN SA11_NP ._SENT Hybridoma_NP cells_NNS producing_VBG the_DT SA11-neutralizing_NP ,_, anti-VP4_NP MAb_NP 2G4_NP were_VBD provided_VBN by_IN M._NP Estes_NP and_CC J._NP Burns_NP ,_, Baylor_NP College_NP of_IN Medicine_NP ,_, Houston_NP ,_, Tex._NP By_IN fluorescent_JJ focus_NN reduction_NN neutralization_NN assay_NN ,_, the_DT titer_NN of_IN MAb_NP 2G4_JJ ascitic_JJ fluid_NN against_IN SA11_NP was_VBD 1:40,000_CD ._SENT The_DT derivation_NN of_IN antirotavirus_NP MAbs_NP RVA_NP (_( to_TO VP6_NP )_) ,_, 60_CD (_( to_TO a_DT VP7_JJ nonneutralization_JJ epitope_NN )_) ,_, and_CC RV-3:5_NP (_( to_TO a_DT VP7_JJ neutralization_NN epitope_NN )_) has_VBZ been_VBN described_VBN previously_RB ._SENT MAbs_NP P4C10_NP ,_, QE2.E5_NP ,_, and_CC P5D2_NP to_TO human_JJ beta1_NN were_VBD provided_VBN by_IN D._NP Leavesley_NP and_CC P._NP Simmons_NP ,_, Royal_NP Adelaide_NP Hospital_NP ,_, Adelaide_NP ,_, South_NP Australia_NP ,_, Australia_NP (_( P4C10_NP ,_, QE2.E5_NP ,_, and_CC P5D2_NP )_) ,_, and_CC E._NP Wayner_NP ,_, Fred_NP Hutchinson_NP Cancer_NP Research_NP Center_NP ,_, Seattle_NP ,_, Wash._NP (_( P4C10_NP and_CC P5D2_NP )_) ._SENT Anti-human_NP alpha2_NP MAbs_NP AK7_NP ,_, which_WDT (_( according_VBG to_TO flow_VB cytometry_NN results_NNS )_) binds_VBZ MA104_NP cell_NN surface-expressed_VBD alpha2beta1_JJ integrin_NN and_CC blocks_VBZ SA11_JJ infection_NN of_IN MA104_NP cells_NNS by_IN 50_CD to_TO 60_CD %_NN at_IN 12_CD to_TO 40_CD mug/ml_NN ,_, and_CC P1E6_NP were_VBD purchased_VBN from_IN Pharmingen_NP ,_, San_NP Diego_NP ,_, Calif._NP ,_, and_CC Invitrogen_NP ,_, Burwood_NP ,_, Victoria_NP ,_, Australia_NP ,_, respectively_RB ._SENT Anti-human_NP alpha2_NP MAb_NP 12F1_JJ and_CC anti-beta1_JJ MAb_NP B3B11_NP were_VBD purchased_VBN from_IN Chemicon_NP ,_, Temecula_NP ,_, Calif._NP Purified_NP anti-human_NP alpha2_NP MAbs_NP HAS3_NP and_CC HAS4_NP were_VBD provided_VBN by_IN F._NP Watt_NP ,_, Imperial_NP Cancer_NP Research_NP Fund_NP ,_, London_NP ,_, England_NP ._SENT The_DT epitopes_NNS recognized_VBN by_IN the_DT anti-integrin_NN MAbs_NNS used_VBN are_VBP listed_VBN in_IN Table_NP ._SENT The_DT pan-class_JJ I-reactive_NP MAb_NP W6/32_NP was_VBD provided_VBN by_IN A._NP Brooks_NP ,_, Department_NP of_IN Microbiology_NP and_CC Immunology_NP ,_, The_DT University_NP of_IN Melbourne_NP ,_, Melbourne_NP ,_, Victoria_NP ,_, Australia_NP ._SENT Negative_JJ control_NN MAbs_NP MOPC21_NP (_( purchased_VBN from_IN Cappel_NP ,_, ICN_NP Pharmaceuticals_NPS Inc._NP ,_, Aurora_NP ,_, Ohio_NP )_) and_CC RV5:2_NP (_( specific_JJ to_TO RV-5_NP rotavirus_NP VP4_NP )_) were_VBD matched_VBN with_IN test_NN MAbs_NNS for_IN isotype_NN and_CC protein_NN concentration_NN ._SENT Binding_VBG of_IN MAbs_NNS to_TO cells_NNS was_VBD characterized_VBN by_IN flow_NN cytometry_NN and_CC expressed_VBD as_IN the_DT relative_JJ linear_JJ median_JJ fluorescence_NN intensity_NN (_( MFI_NP )_) ,_, as_RB described_VBN previously_RB ._SENT Immunoprecipitation_NN of_IN integrin_NN subunits_NN using_VBG virus_NN or_CC anti-integrin_NN antibodies_NNS ._SENT |_SYM Surface_NP proteins_NNS on_IN confluent_JJ cell_NN monolayers_NNS (_( 5_CD x_SYM 107_CD cells_NNS )_) were_VBD biotinylated_JJ as_RB described_VBN previously_RB ,_, and_CC then_RB cells_NNS were_VBD lysed_VBN in_IN 50_CD mM_NP Tris-HCl_NP buffer_NN (_( pH_NN 7.5_CD )_) containing_VBG 5_CD mM_NP iodoacetamide_NN (_( Sigma_NP ,_, St._NP Louis_NP ,_, Mo._NP )_) ,_, 1_CD mM_NP phenylmethylsulfonyl_NN fluoride_NN (_( Sigma_NP )_) ,_, 1_CD mM_NP CaCl2_NP ,_, 1_CD mM_NP MgCl2_NP ,_, and_CC 0.5_CD %_NN (_( vol/vol_NN )_) Triton_NP X-100_NP (_( Sigma_NP )_) for_IN 30_CD min_NN at_IN 4C_JJ ._SENT Lysates_NNS were_VBD clarified_VBN by_IN centrifugation_NN at_IN 10,000_CD x_NN g_NN for_IN 10_CD min_NN at_IN 4C_JJ ,_, and_CC lysate_JJ protein_NN concentrations_NNS were_VBD determined_VBN using_VBG a_DT detergent-compatible_JJ protein_NN assay_NN kit_NN (_( Bio-Rad_NP ,_, Hercules_NP ,_, Calif._NP )_) ._SENT Purified_VBN virus_NN infectivity_NN was_VBD activated_VBN with_IN porcine_JJ trypsin_NN type_NN IX-S_NP (_( Sigma_NP )_) (_( 10_CD mug/ml_NN )_) for_IN 10_CD min_NN at_IN 37C_JJ ._SENT Activated_VBN virus_NN (_( 5_CD mug_NN ;_: 107_CD to_TO 108_CD infectious_JJ virions_NNS )_) was_VBD mixed_VBN with_IN cell_NN lysate_NNS (_( 70_CD mug_NN of_IN protein_NN in_IN 500_CD mul_NN of_IN phosphate-buffered_JJ saline_NN [_SYM PBS_NP ]_SYM )_) overnight_RB at_IN 4C_JJ ._SENT Anti-rotavirus_NP Ab_NP was_VBD added_VBN to_TO a_DT final_JJ dilution_NN of_IN 1:100_CD for_IN 1_CD h_NN at_IN 4C_JJ ,_, and_CC Ab_NP complexes_NNS were_VBD collected_VBN onto_IN protein_NN A-Sepharose_JJ beads_NNS (_( Amersham_NP Pharmacia_NP Biotech_NP ,_, Uppsala_NP ,_, Sweden_NP )_) (_( 2_CD mg_NN in_IN 100_CD mul_NN )_) which_WDT had_VBD been_VBN blocked_VBN for_IN 1_CD h_NN at_IN 4C_JJ in_IN PBS_NP containing_VBG 5_CD %_NN (_( wt/vol_NN )_) skim_NN milk_NN powder_NN (_( Diploma_NP ;_: Bonlac_NP Foods_NPS ,_, Altona_NP ,_, Australia_NP )_) ._SENT Beads_NNS were_VBD collected_VBN by_IN centrifugation_NN at_IN 10,000_CD x_NN g_NN for_IN 10_CD s_NNS and_CC washed_VBN extensively_RB with_IN PBS_NP ._SENT For_IN MAb_NP precipitations_NNS ,_, cell_NN extract_NN (_( 70_CD mug_NN of_IN protein_NN )_) was_VBD reacted_VBN with_IN 5_CD to_TO 10_CD mug_NN of_IN MAb_NP for_IN 1_CD to_TO 16_CD h_NN at_IN 4C_JJ ._SENT For_IN precipitation_NN of_IN alpha2beta1_NN from_IN MA104_NP cell_NN lysates_NNS with_IN alpha2-specific_JJ MAbs_NNS ,_, MAb-cell_JJ protein_NN complexes_NNS were_VBD collected_VBN with_IN protein_NN A-Sepharose_NN beads_NNS that_WDT had_VBD been_VBN coated_VBN with_IN rabbit_NN anti-mouse_NN immunoglobulins_NNS (_( Ig_NP )_) (_( Dako_NP ,_, Germany_NP )_) (_( 0.2_CD mg_NN anti-mouse_NN Ig_NP ,_, mainly_RB IgG_NP ,_, per_IN 20_CD mg_NN of_IN beads_NNS )_) overnight_RB at_IN 4C_JJ and_CC washed_VBN extensively_RB with_IN PBS_NP ._SENT For_IN all_DT other_JJ MAb_NP precipitations_NNS ,_, Ab_NP complexes_NNS were_VBD collected_VBN onto_IN blocked_VBN protein_NN A-Sepharose_NN beads_NNS as_RB described_VBD above_IN for_IN virus_NN complexes_NNS ._SENT Precipitated_VBD proteins_NNS were_VBD separated_VBN from_IN beads_NNS by_IN boiling_VBG for_IN 5_CD min_NN in_IN Laemmli_NP 's_POS sample_NN buffer_NN containing_VBG 5_CD %_NN (_( vol/vol_NN )_) beta-mercaptoethanol_NN ._SENT Proteins_NNS and_CC protein_NN molecular_JJ weight_NN standards_NNS (_( Novex_NP ,_, San_NP Diego_NP ,_, Calif._NP )_) were_VBD separated_VBN by_IN sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN in_IN a_DT 7.5_CD %_NN (_( wt/vol_NN )_) acrylamide_NN resolving_VBG gel_NN at_IN 125_CD V._NP Proteins_NPS were_VBD electrophoretically_RB transferred_VBN to_TO a_DT polyvinylidene_JJ difluoride_NN membrane_NN (_( Immobilon-P_NP ;_: Millipore_NP ,_, Bedford_NP ,_, Mass._NP )_) for_IN 1_CD h_NN at_IN 100_CD V._NP After_IN blocking_VBG in_IN PBS_NP containing_VBG 0.1_CD %_NN (_( vol/vol_NN )_) Tween_NP 20_NP (_( PBS-T_NP )_) and_CC 5_CD %_NN (_( wt/vol_NN )_) skim_NN milk_NN powder_NN for_IN 1_CD h_NN at_IN 37C_JJ or_CC overnight_JJ at_IN 4C_JJ ,_, the_DT membrane_NN was_VBD washed_VBN extensively_RB with_IN PBS-T_NP ._SENT Biotinylated_JJ proteins_NNS were_VBD detected_VBN by_IN incubation_NN with_IN streptavidin-conjugated_JJ horseradish_NN peroxidase_NN (_( StAv-HRP_NP )_) (_( Silenus_NP ,_, Melbourne_NP ,_, Victoria_NP ,_, Australia_NP )_) ,_, optimally_RB diluted_VBN in_IN PBS-T_NP ,_, for_IN 1_CD h_NN at_IN 20C_JJ ._SENT Following_VBG washing_NN as_RB described_VBD above_IN ,_, bound_VBN StAv-HRP_NP was_VBD detected_VBN by_IN enhanced_JJ chemiluminescence_NN (_( ECL_NP )_) with_IN ECL_NP Hyperfilm_NP (_( Amersham_NP Pharmacia_NP Biotech_NP )_) as_IN specified_VBN by_IN the_DT manufacturer_NN ,_, the_DT positions_NNS of_IN molecular_JJ weight_NN markers_NNS were_VBD marked_VBN ,_, and_CC films_NNS were_VBD scanned_VBN using_VBG Adobe_NP Photoshop_NP software_NN ._SENT Virus_NN binding_NN ,_, infectivity_NN ,_, and_CC growth_NN assays_NNS ._SENT |_SYM Assays_NP of_IN infectious_JJ rotavirus_NNS binding_VBG to_TO CHO_NP K1_NP cell_NN lines_NNS were_VBD performed_VBN using_VBG confluent_JJ monolayers_NNS in_IN 24-well_JJ trays_NNS (_( Nunclon_NP ,_, Roskilde_NP ,_, Denmark_NP )_) as_IN previously_RB described_VBN ._SENT Harvested_VBN virus_NN titers_NNS were_VBD determined_VBN by_IN indirect_JJ immunofluorescent_NN staining_VBG of_IN confluent_JJ MA104_NP cell_NN monolayers_NNS inoculated_VBN with_IN serial_JJ dilutions_NNS of_IN virus_NN and_CC were_VBD expressed_VBN as_IN the_DT number_NN of_IN fluorescent_JJ cell-forming_JJ units_NNS (_( FCFU_NP )_) per_IN well_RB ._SENT For_IN MAb_NP blockade_NN of_IN rotavirus_NN binding_NN ,_, washed_VBN cell_NN monolayers_NNS were_VBD incubated_VBN with_IN MAbs_NP (_( 200_CD mul/well_NN )_) at_IN 37C_JJ for_IN 1.5_CD h_NN and_CC then_RB cooled_VBN to_TO 4C_JJ prior_RB to_TO MAb_NP removal_NN and_CC virus_NN addition_NN for_IN the_DT binding_JJ assay_NN ._SENT Rotavirus_NN infectivity_NN in_IN CHO_NP cell_NN lines_NNS was_VBD quantitated_VBN using_VBG confluent_JJ monolayers_NNS in_IN 96-well_NN trays_NNS (_( Nunclon_NP )_) ,_, as_RB described_VBN previously_RB ._SENT In_IN some_DT experiments_NNS ,_, virus_NN was_VBD not_RB trypsin_NN activated_VBN to_TO maintain_VB cellular_JJ integrity_NN ._SENT The_DT number_NN of_IN virus-infected_JJ CHO_NP cells_NNS was_VBD determined_VBN (_( using_VBG MAb_NP RVA_NP at_IN a_DT 1:2,000_CD dilution_NN )_) by_IN indirect_JJ immunofluorescent_NN staining_VBG ._SENT Rotavirus_NP infection_NN blockade_NN (_( using_VBG anti-integrin_NP MAbs_NP )_) in_IN MA104_NP cells_NNS was_VBD performed_VBN using_VBG the_DT fluorescent_JJ focus_NN reduction_NN assay_NN described_VBD previously_RB ,_, and_CC growth_NN curves_NNS were_VBD obtained_VBN using_VBG confluent_JJ MA104_NP or_CC CHO_NP cells_NNS in_IN 24-well_JJ trays_NNS as_RB described_VBD previously_RB ._SENT Assay_NN for_IN MAb_NP AK7_JJ binding_NN to_TO the_DT alpha2_JJ integrin_NN I_NP domain_NN ._SENT |_SYM Soluble_JJ glutathione_NN S-transferase-alpha2_NP I_CD domain_NN (_( GST-alpha2I_NP )_) and_CC wild-type_NP GST_NP (_( wt-GST_NP )_) were_VBD produced_VBN and_CC purified_VBN as_IN described_VBN previously_RB ,_, and_CC their_PP$ binding_NN to_TO MAb_NP AK7_NP was_VBD determined_VBN using_VBG an_DT EIA_NP adapted_VBD from_IN earlier_JJR studies_NNS ._SENT Microtiter_NN plates_NNS (_( Immunosorb_NP ;_: Nunclon_NP )_) were_VBD coated_VBN with_IN GST-alpha2I_NP or_CC wt-GST_NP diluted_VBN in_IN PBS_NP ,_, at_IN 0_CD to_TO 500_CD mug/ml_NN ,_, for_IN 2_CD h_NN at_IN 37C_JJ ._SENT MAbs_NP (_( 10_CD mug/ml_NN )_) diluted_VBN in_IN PBS_NP containing_VBG 2.5_CD %_NN skim_NN milk_NN powder_NN and_CC 0.05_CD %_NN (_( vol/vol_NN )_) Tween_NP 20_NP (_( Sigma_NP )_) were_VBD reacted_VBN overnight_RB at_IN 4C_JJ ._SENT Bound_NP MAb_NP was_VBD detected_VBN using_VBG HRP-conjugated_NP anti-mouse_NP Ig_NP (_( Silenus_NP )_) ._SENT Statistical_JJ analysis_NN ._SENT |_SYM The_DT unpaired_JJ ,_, two-tailed_JJ Student_NP t_NN test_NN or_CC two-way_JJ analysis_NN of_IN variance_NN was_VBD used_VBN to_TO assess_VB the_DT statistical_JJ significance_NN of_IN differences_NNS in_IN virus-cell_NN binding_NN and_CC infectivity_NN ._SENT Significance_NN was_VBD set_VBN at_IN the_DT 95_CD %_NN level_NN ._SENT Unless_IN otherwise_RB stated_VBN ,_, error_NN bars_NNS represent_VBP the_DT 95_CD %_NN confidence_NN interval_NN and_CC the_DT data_NNS presented_VBN in_IN each_DT figure_NN were_VBD derived_VBN from_IN at_IN least_JJS three_CD experiments_NNS ._SENT Rotaviruses_NNS specifically_RB precipitate_VBP MA104_NP and_CC Caco-2_NP cell_NN surface_NN proteins_NNS that_WDT migrate_VBP indistinguishably_RB from_IN those_DT immunoprecipitated_NN by_IN MAbs_NP to_TO alpha2beta1_NN ._SENT |_SYM The_DT proteins_NNS precipitated_VBD by_IN purified_VBN SA11_NN from_IN lysates_NNS of_IN surface-biotinylated_JJ MA104_NP cells_NNS and_CC collected_JJ using_VBG anti-SA11_NN are_VBP shown_VBN in_IN Fig._NN ._SENT Precipitated_VBN proteins_NNS ranged_VBN in_IN molecular_JJ mass_NN from_IN approximately_RB 160_CD to_TO 30_CD kDa_NN ._SENT Apart_RB from_IN a_DT nonspecifically_RB detected_VBN protein_NN migrating_VBG at_IN 50_CD kDa_NNS that_WDT was_VBD present_JJ in_IN all_DT precipitations_NNS ,_, no_DT proteins_NNS were_VBD precipitated_VBN by_IN control_NN Ab_NP in_IN the_DT presence_NN of_IN virus_NN or_CC by_IN anti-SA11_NN in_IN the_DT absence_NN of_IN virus_NN ._SENT To_TO confirm_VB that_IN the_DT proteins_NNS visualized_VBN were_VBD biotinylated_JJ and_CC derived_VBN from_IN the_DT cell_NN surface_NN ,_, proteins_NNS precipitated_VBD by_IN SA11_NP and_CC collected_JJ using_VBG anti-SA11_NN from_IN lysates_NNS of_IN mock-biotinylated_JJ MA104_NP cells_NNS were_VBD compared_VBN with_IN those_DT obtained_VBN from_IN cell_NN surface-biotinylated_JJ lysates_NNS ._SENT The_DT two_CD proteins_NNS of_IN 140_CD and_CC 160_CD kDa_NN (_( present_JJ in_IN virus_NN precipitates_NNS of_IN biotinylated_JJ MA104_NP cell_NN lysates_NNS )_) were_VBD the_DT only_JJ proteins_NNS not_RB visualized_VBN from_IN virus_NN precipitates_NNS of_IN mock-biotinylated_JJ lysates_NNS ._SENT Thus_RB ,_, these_DT were_VBD the_DT only_JJ biotin-accessible_JJ proteins_NNS on_IN the_DT MA104_NP cell_NN surface_NN that_WDT were_VBD specifically_RB precipitated_VBN by_IN SA11_NP ._SENT The_DT nonbiotinylated_JJ proteins_NNS of_IN 120_CD kDa_NNS or_CC less_JJR proved_VBD to_TO be_VB viral_JJ in_IN origin_NN ,_, as_IN they_PP migrated_VBD in_IN gels_NNS indistinguishably_RB from_IN the_DT VP1_NP ,_, VP2_NP ,_, VP5*_NP ,_, VP6_NP ,_, and_CC VP7_JJ proteins_NNS solubilized_VBN from_IN purified_VBN SA11_JJ rotavirus_NN ._SENT They_PP were_VBD precipitated_VBN by_IN anti-SA11_JJ only_RB in_IN the_DT presence_NN of_IN virus_NN and_CC were_VBD detected_VBN in_IN the_DT presence_NN or_CC absence_NN of_IN MA104_NP cell_NN proteins_NNS ._SENT Sufficient_JJ viral_JJ protein_NN ,_, but_CC not_RB 140-_CD and_CC 160-kDa_NP proteins_NNS ,_, was_VBD precipitated_VBN to_TO be_VB visible_JJ on_IN Coomassie_NP blue-stained_JJ gels_NNS ,_, suggesting_VBG that_IN ECL_NP was_VBD detecting_VBG the_DT large_JJ amounts_NNS of_IN viral_JJ proteins_NNS present_JJ in_IN the_DT precipitations_NNS nonspecifically_RB ._SENT This_DT nonspecific_JJ reaction_NN was_VBD not_RB eliminated_VBN by_IN StAv-HRP_NP concentration_NN optimization_NN or_CC alternative_JJ blocking_VBG reagents_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Streptavidin_NP can_MD bind_VB to_TO peptides_NNS of_IN sequences_NNS unrelated_JJ to_TO biotin_NN ._SENT As_IN shown_VBN in_IN Fig._NN ,_, RRV_NP bound_VBD to_TO 140-_CD and_CC 160-kDa_NP proteins_NNS was_VBD precipitated_VBN by_IN anti-SA11_NN from_IN MA104_NP cell_NN lysates_NNS ._SENT As_IN SA11_NP and_CC RRV_NP share_NN VP4_NP and_CC VP7_JJ serotype_NN specificity_NN ,_, these_DT antisera_NN can_MD be_VB used_VBN interchangeably_RB ._SENT Anti-SA11_NN was_VBD used_VBN rather_RB than_IN anti-RRV_NP ,_, as_IN the_DT anti-SA11_JJ serum_NN showed_VBD a_DT higher_JJR neutralization_NN and_CC EIA_NP titer_NN to_TO both_DT SA11_NP and_CC RRV_NP than_IN did_VBD the_DT anti-RRV_NP serum_NN ._SENT Consistent_JJ with_IN the_DT lower_JJR titer_NN of_IN anti-RRV_NP against_IN SA11_NP ,_, SA11_JJ that_IN bound_VBN to_TO the_DT 140-kDa_NP but_CC not_RB the_DT 160-kDa_NP protein_NN was_VBD precipitated_VBN by_IN anti-RRV_NP from_IN MA104_NP cell_NN lysates_NNS ._SENT Anti-VP4_NP MAb_NP 2G4_JJ precipitated_VBD virus_NN complexed_VBN with_IN both_CC the_DT 140-_CD and_CC 160-kDa_NP MA104_NP cell_NN proteins_NNS similarly_RB to_TO anti-SA11_JJ and_CC more_RBR readily_RB detected_VBN the_DT 140-kDa_NP protein_NN ._SENT MAb_NP 2G4_NP did_VBD not_RB precipitate_VB the_DT 140-_CD and_CC 160-kDa_NP MA104_NP cell_NN proteins_NNS in_IN the_DT absence_NN of_IN virus_NN ._SENT Neither_DT protein_NN was_VBD detected_VBN using_VBG MAbs_NP RVA_NP (_( VP6_NP )_) ,_, 60_NP (_( VP7_NP )_) ,_, RV-3:5_NP (_( VP7_NP )_) ,_, or_CC MOPC21_JJ (_( negative_JJ control_NN )_) ._SENT The_DT 160-_CD and_CC 140-kDa_NP proteins_NNS precipitated_VBD by_IN SA11_NP are_VBP comparable_JJ in_IN size_NN with_IN the_DT human_JJ alpha2_NN (_( approximately_RB 165_CD kDa_NN )_) and_CC beta1_JJ (_( approximately_RB 130_CD kDa_NN )_) integrin_NN subunits_NN and_CC so_RB might_MD correspond_VB to_TO alpha2beta1_NN ._SENT We_PP therefore_RB analyzed_VBD the_DT abilities_NNS of_IN two_CD anti-alpha2_JJ MAbs_NNS to_TO recognize_VB alpha2beta1_JJ on_IN MA104_NP cells_NNS and_CC inhibit_VB virus_NN infection_NN of_IN these_DT cells_NNS ._SENT MAb_NP P1E6_NP bound_VBN to_TO MA104_NP cell_NN surface-expressed_VBD alpha2beta1_JJ similarly_RB to_TO MAb_NP AK7_NP according_VBG to_TO flow_VB cytometry_NN ,_, as_IN the_DT histograms_NNS obtained_VBN with_IN the_DT two_CD MAbs_NNS used_VBN at_IN the_DT same_JJ concentrations_NNS were_VBD indistinguishable_JJ (_( data_NNS not_RB shown_VBN )_) ._SENT P1E6_NP and_CC AK7_NP showed_VBD similar_JJ ratios_NNS of_IN the_DT MFI_NP with_IN anti-integrin_NP MAb_NP to_TO the_DT MFI_NP with_IN control_NN MAb_NP +-_NN range_NN (_( 7.23_CD +-_NN 0.48_CD and_CC 6.41_CD +-_NN 0.57_CD ,_, respectively_RB )_) (_( data_NNS not_RB shown_VBN )_) ._SENT MAb_NP P1E6_NP also_RB blocked_VBD SA11_JJ infection_NN of_IN MA104_NP cells_NNS by_IN a_DT mean_JJ range_NN of_IN 39_CD %_NN +-_NN 7.1_CD %_NN at_IN 40_CD mug/ml_NN (_( P_NN =_SYM 0.04_CD )_) ._SENT As_IN illustrated_VBN in_IN Fig._NN with_IN data_NNS obtained_VBN with_IN MAb_NP P1E6_NP ,_, both_DT anti-alpha2_JJ MAbs_NP AK7_NP and_CC P1E6_NP immunoprecipitated_VBD two_CD proteins_NNS of_IN the_DT expected_VBN molecular_JJ mass_NN for_IN the_DT alpha2_JJ and_CC beta1_JJ integrin_NN subunits_NN from_IN cell_NN surface-biotinylated_JJ MA104_NP cell_NN extracts_VBZ which_WDT migrated_VBD indistinguishably_RB from_IN the_DT 160-_CD and_CC 140-kDa_NP proteins_NNS precipitated_VBD by_IN SA11_NP ._SENT Although_IN anti-beta1_JJ MAbs_NP P4C10_NP ,_, P5D2_NP ,_, and_CC QE2.E5_NP also_RB immunoprecipitated_VBD both_CC the_DT alpha2_JJ and_CC beta1_JJ integrin_NN subunits_NN ,_, these_DT anti-beta1_NP MAbs_NP immunoprecipitated_VBD the_DT beta1_JJ integrin_NN subunit_NN to_TO a_DT greater_JJR extent_NN than_IN the_DT alpha2_JJ subunit_NN ._SENT This_DT is_VBZ shown_VBN in_IN Fig._NN for_IN MAb_NP QE2.E5_NP ._SENT The_DT alpha2_JJ band_NN precipitated_VBD by_IN QE2.E5_NP is_VBZ not_RB visible_JJ in_IN Fig._NN ,_, as_IN exposure_NN of_IN the_DT film_NN sufficient_JJ to_TO visualize_VB alpha2_NN greatly_RB overexposed_VBD the_DT beta1_JJ band_NN ._SENT This_DT is_VBZ expected_VBN ,_, as_IN beta1_JJ partners_NNS several_JJ alpha_NN subunits_NN ,_, whereas_IN alpha2_JJ partners_NNS only_RB beta1_JJ ._SENT Control_NP MAbs_NP did_VBD not_RB precipitate_VB these_DT proteins_NNS ._SENT Anti-beta1_JJ MAb_NP B3B11_NP recognized_VBD a_DT single_JJ protein_NN of_IN approximately_RB 140_CD kDa_NN ,_, according_VBG to_TO Western_NP blotting_VBG of_IN whole_JJ MA104_NP cell_NN lysate_NNS directly_RB applied_VBN to_TO the_DT gel_NN (_( data_NNS not_RB shown_VBN )_) ._SENT As_IN each_DT integrin_NN subunit-specific_JJ MAb_NP precipitated_VBD both_DT subunits_NN from_IN cell_NN lysates_NNS ,_, a_DT significant_JJ proportion_NN of_IN the_DT alpha2_JJ and_CC beta1_JJ subunits_NN in_IN the_DT lysates_NNS retained_VBD their_PP$ noncovalent_JJ association_NN ,_, which_WDT is_VBZ required_VBN for_IN efficient_JJ ligand_NN interaction_NN ._SENT Although_IN the_DT intensity_NN of_IN the_DT 140-kDa_NP band_NN tended_VBD to_TO be_VB higher_JJR than_IN that_DT of_IN the_DT 160-kDa_NP band_NN in_IN SA11_JJ precipitations_NNS ,_, the_DT 160-_CD and_CC 140-kDa_NP protein_NN bands_NNS precipitated_VBD by_IN anti-alpha2_JJ MAbs_NNS were_VBD approximately_RB equal_JJ in_IN intensity_NN ._SENT This_DT suggests_VBZ that_IN the_DT alpha2_JJ and_CC beta1_JJ proteins_NNS were_VBD labeled_VBN to_TO a_DT similar_JJ extent_NN with_IN biotin_NN and_CC that_IN SA11_NP may_MD have_VB been_VBN precipitating_VBG more_RBR 140-_JJ than_IN 160-kDa_NP protein_NN ._SENT However_RB ,_, it_PP is_VBZ also_RB possible_JJ that_IN these_DT differences_NNS resulted_VBN from_IN the_DT nonquantitative_JJ nature_NN of_IN the_DT immunoprecipitation_NN and_CC protein_NN visualization_NN techniques_NNS ._SENT Overall_RB ,_, these_DT data_NNS suggest_VBP that_IN the_DT 140-_CD and_CC 160-kDa_NP MA104_NP cell_NN surface_NN proteins_NNS bound_VBN by_IN SA11_JJ rotavirus_NNS are_VBP the_DT alpha2_JJ and_CC beta1_JJ integrin_NN subunits_NN ._SENT Possibly_RB ,_, SA11_NP precipitates_VBZ free_JJ beta1_JJ integrin_NN ,_, as_RB well_RB as_IN alpha2beta1_NN ,_, from_IN MA104_NP cell_NN lysates_NNS ._SENT As_IN shown_VBN in_IN Fig._NN ,_, SA11_NP precipitated_VBD a_DT similar_JJ range_NN of_IN proteins_NNS from_IN Caco-2_JJ cell_NN lysates_NNS as_IN from_IN MA104_NP cell_NN lysates_NNS ._SENT The_DT exceptions_NNS were_VBD that_IN a_DT 130-kDa_NP Caco-2_NP protein_NN was_VBD precipitated_VBN ,_, rather_RB than_IN a_DT 140-kDa_NP protein_NN ,_, and_CC two_CD Caco-2_JJ cell_NN proteins_NNS of_IN approximately_RB 165_CD and_CC 160_CD kDa_NNS were_VBD resolved_VBN in_IN several_JJ experiments_NNS ._SENT No_DT SA11-bound_JJ proteins_NNS were_VBD precipitated_VBN by_IN control_NN Ab_NP (_( Fig._NN and_CC B_NN )_) ._SENT The_DT origin_NN of_IN the_DT Caco-2_NP cell_NN proteins_NNS visualized_VBN was_VBD determined_VBN by_IN comparison_NN of_IN proteins_NNS precipitated_VBN by_IN SA11_NP from_IN mock-_NN and_CC surface-biotinylated_JJ cell_NN lysates_NNS and_CC in_IN the_DT absence_NN or_CC presence_NN of_IN cell_NN lysate_NNS ._SENT As_IN the_DT proteins_NNS of_IN approximately_RB 120_CD kDa_NN or_CC less_RBR precipitated_VBD from_IN biotinylated_JJ lysates_NNS were_VBD also_RB present_JJ in_IN precipitates_NNS from_IN mock-biotinylated_JJ Caco-2_NP cell_NN lysates_NNS and_CC in_IN the_DT absence_NN of_IN lysate_NNS ,_, only_RB the_DT three_CD proteins_NNS at_IN approximately_RB 165_CD ,_, 160_CD ,_, and_CC 130_CD kDa_NNS precipitated_VBN by_IN SA11_NP originated_VBN from_IN the_DT Caco-2_NP cell_NN surface_NN ._SENT These_DT SA11-precipitated_NP proteins_NNS migrated_VBD indistinguishably_RB from_IN the_DT two_CD Caco-2_NP cell_NN proteins_NNS precipitated_VBD by_IN anti-beta1_JJ MAb_NP P5D2_NP and_CC anti-alpha2_NP MAb_NP P1E6_NP ._SENT The_DT 165-_CD and_CC 160-kDa_NP proteins_NNS precipitated_VBD with_IN virus_NN could_MD not_RB be_VB resolved_VBN sufficiently_RB to_TO determine_VB which_WDT protein_NN comigrated_VBD with_IN the_DT 160-kDa_NP alpha2_NN integrin_NN band_NN precipitated_VBD by_IN MAb_NP P1E6_NP ._SENT Control_NP MAbs_NP RV-5:2_NP and_CC MOPC21_NP did_VBD not_RB precipitate_VB alpha2beta1_JJ ._SENT The_DT protein_NN precipitated_VBD by_IN RV-5:2_NP that_WDT migrated_VBD near_JJ beta1_NN did_VBD not_RB comigrate_NN with_IN beta1_NN in_IN gels_NNS with_IN increased_VBN protein_NN separation_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Thus_RB ,_, the_DT 130-_CD and_CC 160-_CD or_CC 165-kDa_NP Caco-2_NP cell_NN surface_NN proteins_NNS bound_VBN by_IN SA11_NP appear_VBP to_TO include_VB alpha2_JJ and_CC beta1_JJ ._SENT Differences_NNS in_IN integrin_NN glycosylation_NN between_IN MA104_NP and_CC Caco-2_NP cells_NNS might_MD explain_VB the_DT difference_NN in_IN sizes_NNS estimated_VBN for_IN the_DT beta1_JJ subunit_NN in_IN MA104_NP (_( 140_CD kDa_NNS )_) and_CC Caco-2_NP (_( 130_CD kDa_NN )_) cells_NNS ._SENT In_IN contrast_NN to_TO the_DT results_NNS of_IN MA104_NP cell_NN studies_NNS ,_, SA11_NP precipitated_VBD similar_JJ amounts_NNS of_IN the_DT 160-_CD or_CC 165-_CD and_CC 130-kDa_NP proteins_NNS as_RB judged_VBN by_IN band_NN intensity_NN ._SENT No_DT surface-biotinylated_JJ Caco-2_NP cell_NN proteins_NNS were_VBD visualized_VBN in_IN precipitations_NNS with_IN purified_VBN Wa_NP ._SENT As_IN the_DT maximum_JJ ratio_NN of_IN infectivity_NN (_( FCFU_NP )_) to_TO micrograms_NNS of_IN protein_NN obtainable_JJ with_IN Wa_NP (_( 6.8_CD x_SYM 105_CD )_) was_VBD 10-_CD to_TO 67-fold_NN less_JJR than_IN that_DT obtained_VBN with_IN SA11_NP ,_, it_PP appears_VBZ that_IN the_DT amount_NN of_IN infectious_JJ Wa_NP obtainable_JJ was_VBD insufficient_JJ for_IN detection_NN of_IN Wa_NP binding_VBG to_TO lysate_JJ proteins_NNS ._SENT Under_IN standardized_JJ assay_NN conditions_NNS which_WDT included_VBD using_VBG identical_JJ MAbs_NNS at_IN the_DT same_JJ concentrations_NNS ,_, anti-alpha2_JJ and_CC anti-beta1_JJ MAbs_NNS precipitated_VBD more_JJR alpha2beta1_JJ integrin_NN from_IN Caco-2_JJ cells_NNS than_IN from_IN MA104_NP cells_NNS ,_, as_RB judged_VBN by_IN the_DT intensity_NN of_IN staining_VBG of_IN the_DT protein_NN bands_NNS ._SENT This_DT is_VBZ consistent_JJ with_IN the_DT finding_NN of_IN a_DT higher_JJR level_NN of_IN alpha2beta1_JJ expression_NN on_IN Caco-2_JJ cells_NNS than_IN on_IN MA104_NP cells_NNS as_RB detected_VBD by_IN flow_NN cytometry_NN ._SENT The_DT amount_NN of_IN alpha2beta1_NN precipitated_VBD by_IN the_DT MAbs_NP also_RB would_MD have_VB been_VBN affected_VBN by_IN their_PP$ specificity_NN for_IN human_JJ rather_RB than_IN monkey_NN integrins_NNS ._SENT N-terminal_JJ sequence_NN determination_NN and_CC Western_JJ blotting_VBG with_IN the_DT anti-beta1_JJ MAb_NP B3B11_NP that_WDT detected_VBD beta1_JJ in_IN whole_JJ MA104_NP cell_NN lysate_NN of_IN the_DT 160-_CD and_CC 140-kDa_NP proteins_NNS precipitated_VBD by_IN SA11_NP from_IN cell_NN lysates_NNS were_VBD unsuccessful_JJ due_RB to_TO insufficient_JJ amounts_NNS of_IN protein_NN for_IN analysis_NN ._SENT Mapping_NN of_IN MAb_NP AK7_JJ to_TO the_DT alpha2_JJ I_NP domain_NN and_CC flow_NN cytometry_NN characterization_NN of_IN integrin-transfected_JJ CHO_NP cells_NNS ._SENT |_SYM As_RB shown_VBN in_IN Fig._NN ,_, AK7_NP ,_, the_DT most_RBS effective_JJ alpha2-specific_JJ MAb_NN tested_VBN for_IN blockade_NN of_IN SA11_NP cell_NN binding_NN and_CC infectivity_NN (_( ,_, ;_: P._NP Halasz_NP and_CC B._NP S._NP Coulson_NP ,_, unpublished_JJ data_NNS )_) ,_, bound_VBN to_TO GST-alpha2I_NP as_RB determined_VBD by_IN EIA_NP ,_, confirming_VBG previous_JJ data_NNS showing_VBG that_IN AK7_JJ maps_NNS to_TO the_DT alpha2_JJ I_NP domain_NN ._SENT Flow_NN cytometry_NN analysis_NN using_VBG MAb_NP HAS4_NP (_( which_WDT maps_VBZ to_TO the_DT N-terminal_JJ region_NN of_IN alpha2_NN outside_IN the_DT I_CD domain_NN [_SYM ,_, ]_SYM )_) and_CC MAb_NP AK7_NP showed_VBD that_IN CHO_NP K1_NP cells_NNS lacked_VBD human_JJ alpha2_NN ,_, CHO_NP alpha2beta1_JJ cells_NNS expressed_VBD both_DT I_NP domain_NN and_CC non-I_NP domain_NN epitopes_NNS ,_, and_CC CHO_NP alpha2delIbeta1_JJ cells_NNS lacked_VBD the_DT I_NP domain_NN but_CC expressed_VBD non-I_NP domain_NN epitopes_NNS similarly_RB to_TO CHO_NP alpha2beta1_JJ cells_NNS ._SENT MAb_NP HAS3_NP maps_VBZ to_TO the_DT same_JJ alpha2_JJ region_NN as_IN MAb_NP HAS4_NP and_CC showed_VBD the_DT same_JJ results_NNS as_IN MAb_NP HAS4_NP (_( data_NN not_RB shown_VBN )_) ._SENT CHO_NP alpha2_NP ,_, CHO_NP alpha2_NP D151A_NP ,_, CHO_NP alpha2_NP T221A_NP ,_, and_CC CHO_NP alpha2_JJ D254A_NP cells_NNS all_RB expressed_VBD the_DT alpha2_JJ I_CD domain_NN AK7_JJ epitope_NN ._SENT Human_JJ beta1_NN (_( combined_VBN with_IN human_JJ alpha2_NN )_) was_VBD present_JJ on_IN CHO_NP alpha2beta1_NP and_CC CHO_NP alpha2delIbeta1_JJ cells_NNS but_CC was_VBD absent_JJ from_IN CHO_NP K1_NP and_CC CHO_NP alpha2_JJ cells_NNS ,_, as_RB expected_VBN ._SENT We_PP calculated_VBD from_IN the_DT flow_NN cytometry_NN histograms_NNS in_IN Fig._NN that_IN approximately_RB 40_CD %_NN of_IN the_DT CHO_NP alpha2beta1_NN cells_NNS expressed_VBD human_JJ alpha2_NN dimerized_VBN with_IN hamster_NN beta1_NN ._SENT These_DT histograms_NNS show_VBP that_IN approximately_RB 55_CD %_NN of_IN the_DT CHO_NP alpha2beta1_NN cells_NNS expressed_VBD human_JJ beta1_NN ,_, as_RB detected_VBD using_VBG MAb_NP QE2.E5_NP ,_, which_WDT is_VBZ specific_JJ for_IN human_JJ beta1_NN and_CC does_VBZ not_RB recognize_VB hamster_NN beta1_NN ._SENT Thus_RB ,_, the_DT remaining_VBG 45_CD %_NN of_IN these_DT cells_NNS expressed_VBD hamster_NN beta1_NN only_RB ._SENT As_IN detected_VBN using_VBG MAbs_NP AK7_NP and_CC HAS4_NP and_CC determined_VBN from_IN the_DT data_NNS presented_VBN in_IN Fig._NN ,_, 86_CD %_NN of_IN CHO_NP alpha2beta1_JJ cells_NNS expressed_VBD human_JJ alpha2_NN ._SENT So_RB ,_, on_IN average_NN ,_, approximately_RB 90_CD %_NN of_IN the_DT CHO_NP alpha2beta1_JJ cells_NNS that_WDT expressed_VBD hamster_NN beta1_NN also_RB expressed_VBD human_JJ alpha2_NN and_CC ,_, overall_RB ,_, approximately_RB 40_CD %_NN (_( calculated_VBN as_IN 90_CD %_NN of_IN 55_CD %_NN )_) of_IN all_PDT the_DT CHO_NP alpha2beta1_NN cells_NNS expressed_VBD human_JJ alpha2_NN dimerized_VBN with_IN hamster_NN beta1_NN ._SENT As_IN the_DT N_NP and_CC C_NP termini_NNS of_IN the_DT I_NP domain_NN are_VBP closely_RB associated_VBN in_IN the_DT three-dimensional_JJ structure_NN and_CC the_DT I_NP domain_NN is_VBZ inserted_VBN as_IN an_DT additional_JJ region_NN sitting_VBG above_IN the_DT alpha_NN subunit_NN in_IN a_DT subset_NN of_IN integrins_NNS ,_, deletion_NN of_IN the_DT I_NP domain_NN is_VBZ expected_VBN not_RB to_TO affect_VB the_DT function_NN of_IN the_DT remaining_VBG regions_NNS of_IN alpha2_JJ or_CC beta1_JJ ,_, and_CC this_DT appears_VBZ to_TO be_VB the_DT case_NN from_IN our_PP$ studies_NNS ._SENT SA11_JJ rotavirus_NN precipitates_VBZ a_DT CHO_NP alpha2beta1_JJ cell_NN surface_NN protein_NN that_WDT migrates_VBZ indistinguishably_RB from_IN beta1_NN and_CC is_VBZ not_RB precipitated_VBN by_IN SA11_NP from_IN CHO_NP K1_NP ,_, CHO_NP alpha2_NP ,_, CHO_NP alpha2delIbeta1_NP ,_, or_CC CHO_NP alpha2_NP T221A_NP cell_NN lysates_NNS ._SENT |_SYM Anti-alpha2_JJ MAbs_NNS immunoprecipitated_JJ two_CD proteins_NNS from_IN CHO_NP alpha2_NP and_CC CHO_NP alpha2beta1_JJ cell_NN lysates_NNS (_( AK7_JJ and_CC P1E6_JJ )_) and_CC from_IN CHO_NP alpha2_JJ Tau221Alpha_NP lysates_NNS (_( P1E6_NP )_) which_WDT migrated_VBD at_IN the_DT expected_VBN molecular_JJ masses_NNS for_IN alpha2beta1_JJ integrin_NN (_( approximately_RB 120_CD and_CC 140_CD kDa_NNS )_) ._SENT No_DT proteins_NNS were_VBD immunoprecipitated_VBN from_IN CHO_NP K1_NP lysates_VBZ and_CC CHO_NP alpha2delIbeta1_JJ cell_NN lysates_NNS (_( data_NNS not_RB shown_VBN )_) by_IN these_DT MAbs_NP ._SENT According_VBG to_TO the_DT results_NNS of_IN Western_NP blotting_VBG of_IN CHO_NP alpha2beta1_NP and_CC CHO_NP alpha2delIbeta1_JJ cell_NN lysates_NNS ,_, anti-beta1_JJ MAb_NP B3B11_NP recognized_VBD a_DT single_JJ protein_NN ,_, of_IN approximately_RB 140_CD kDa_NN that_WDT was_VBD not_RB detected_VBN in_IN CHO_NP K1_NP or_CC CHO_NP alpha2_JJ lysates_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT SA11_NP weakly_RB precipitated_VBD two_CD proteins_NNS ,_, of_IN approximately_RB 140_CD and_CC 120_CD kDa_NN (_( Fig._NN and_CC C_NP )_) ,_, from_IN CHO_NP alpha2beta1_JJ cell_NN lysates_NNS which_WDT were_VBD not_RB precipitated_VBN from_IN CHO_NP K1_NP ,_, CHO_NP alpha2_NN ,_, and_CC CHO_NP alpha2_NP Tau221Alpha_NP lysates_VBZ or_CC CHO_NP alpha2delIbeta1_JJ lysates_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT As_IN shown_VBN in_IN Fig._NN ,_, the_DT 140-kDa_NP protein_NN precipitated_VBD by_IN SA11_NP from_IN CHO_NP alpha2beta1_JJ cells_NNS migrated_VBD indistinguishably_RB from_IN the_DT beta1_JJ integrin_NN subunit_NN immunoprecipitated_VBN in_IN conjunction_NN with_IN the_DT alpha2_JJ subunit_NN by_IN MAb_NP AK7_NP ._SENT As_IN CHO_NP alpha2_NP and_CC CHO_NP alpha2beta1_JJ cells_NNS differ_VBP only_RB in_IN the_DT presence_NN of_IN human_JJ beta1_NN ,_, this_DT shows_VBZ that_IN SA11_NP precipitated_VBD the_DT beta1_JJ integrin_NN from_IN CHO_NP alpha2beta1_JJ cell_NN lysates_NNS ._SENT The_DT inability_NN of_IN SA11_NP to_TO precipitate_VB alpha2_JJ or_CC beta1_JJ from_IN CHO_NP alpha2delIbeta1_JJ cells_NNS suggests_VBZ that_IN the_DT beta1_JJ precipitation_NN from_IN CHO_NP alpha2beta1_JJ cell_NN lysates_NNS was_VBD dependent_JJ on_IN the_DT presence_NN of_IN the_DT alpha2_JJ I_NP domain_NN ._SENT The_DT identity_NN of_IN the_DT 120-kDa_NP protein_NN precipitated_VBD by_IN virus_NN from_IN CHO_NP alpha2beta1_JJ cell_NN lysates_NNS (_( Fig._NN and_CC C_NP )_) is_VBZ unclear_JJ ._SENT It_PP may_MD have_VB been_VBN associated_VBN with_IN beta1_JJ or_CC may_MD have_VB been_VBN viral_JJ in_IN origin_NN ._SENT As_IN shown_VBN in_IN Fig._NN ,_, the_DT beta1_JJ band_NN precipitated_VBD by_IN anti-alpha2_NP MAbs_NP P1E6_NP and_CC AK7_NP appears_VBZ more_RBR intense_JJ than_IN the_DT alpha2_JJ band_NN ._SENT This_DT suggests_VBZ that_IN in_IN contrast_NN to_TO results_NNS with_IN MA104_JJ cells_NNS ,_, the_DT beta1_NN may_MD be_VB more_RBR heavily_RB biotinylated_JJ than_IN the_DT alpha2_NN in_IN CHO_NP cells_NNS ._SENT This_DT could_MD explain_VB the_DT detection_NN of_IN SA11_JJ precipitation_NN of_IN beta1_JJ ,_, but_CC not_RB alpha2_JJ ,_, from_IN CHO_NP alpha2beta1_JJ cell_NN lysates_NNS ._SENT Binding_VBG of_IN SA11_NP and_CC RRV_NP to_TO alpha2beta1_NN and_CC infectivity_NN of_IN SA11_NP in_IN MA104_NP cells_NNS are_VBP blocked_VBN by_IN an_DT anti-alpha2_JJ I_NP domain_NN MAb_NP but_CC not_RB by_IN MAbs_NP directed_VBD to_TO a_DT region_NN of_IN alpha2_NN outside_IN the_DT I_NP domain_NN ._SENT |_SYM At_IN a_DT multiplicity_NN of_IN infection_NN (_( MOI_NP )_) of_IN 5_CD (_( calculated_VBN from_IN MA104_NP infectious_JJ cell_NN titers_NNS )_) and_CC in_IN the_DT absence_NN of_IN any_DT Ab_NP treatment_NN ,_, titers_NNS of_IN SA11_NP and_CC RRV_NP bound_VBN to_TO CHO_NP alpha2beta1_NP and_CC CHO_NP alpha2_NN cells_NNS were_VBD significantly_RB higher_JJR than_IN those_DT of_IN SA11_NP and_CC RRV_NP bound_VBN to_TO CHO_NP K1_NP or_CC CHO_NP K1_NP PBJ-1_NP cells_NNS (_( P_NN <_SYM 0.001_CD )_) (_( Fig._NN and_CC )_) ._SENT CHO_NP alpha2beta1_NP and_CC CHO_NP alpha2_NN cells_NNS bound_VBD 1.6-_CD to_TO 1.7-fold-_JJ and_CC 1.3-fold-higher_JJ titers_NNS of_IN SA11_NP and_CC RRV_NP ,_, respectively_RB ,_, than_IN did_VBD CHO_NP K1_NP or_CC CHO_NP K1_NP PBJ-1_NP cells_NNS ._SENT CHO_NP alpha2beta1_JJ cells_NNS bound_VBN significantly_RB higher_JJR virus_NN titers_NNS than_IN did_VBD CHO_NP alpha2_JJ cells_NNS (_( P_NN <_SYM 0.01_CD )_) ,_, suggesting_VBG that_IN the_DT beta1_JJ subunit_NN plays_VBZ a_DT role_NN in_IN facilitating_VBG virus_NN binding_VBG to_TO alpha2beta1_JJ integrin_NN ._SENT As_IN shown_VBN in_IN Fig._NN ,_, the_DT increase_NN in_IN RRV_NP binding_VBG to_TO CHO_NP alpha2beta1_NP and_CC CHO_NP alpha2_NN cells_NNS was_VBD abolished_VBN by_IN cellular_JJ treatment_NN with_IN MAb_NP AK7_JJ but_CC not_RB with_IN MAbs_NP HAS4_NP and_CC MOPC21_NP ._SENT Similarly_RB ,_, the_DT increased_VBN SA11_NN binding_VBG to_TO CHO_NP alpha2beta1_NP and_CC CHO_NP alpha2_NN cells_NNS was_VBD reduced_VBN to_TO approximately_RB 110_CD %_NN of_IN binding_VBG to_TO CHO_NP K1_NP cells_NNS by_IN treatment_NN with_IN MAb_NP AK7_JJ but_CC not_RB by_IN treatment_NN with_IN MAbs_NP HAS4_NP and_CC MOPC21_NP ._SENT MAb_NP HAS3_NP had_VBD the_DT same_JJ effect_NN as_IN MAb_NP HAS4_NP on_IN SA11_NP and_CC RRV_NP binding_VBG to_TO MA104_NP cells_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Thus_RB ,_, SA11_NP and_CC RRV_NP bind_NN human_JJ alpha2beta1_NN expressed_VBN on_IN CHO_NP K1_NP cells_NNS to_TO a_DT higher_JJR level_NN than_IN to_TO that_DT of_IN human_JJ alpha2_NN dimerized_VBN with_IN hamster_NN beta1_NN and_CC this_DT binding_NN involves_VBZ the_DT alpha2_JJ I_NP domain_NN ._SENT At_IN the_DT maximum_JJ MOI_NP achievable_JJ (_( an_DT MOI_NP of_IN 1_CD )_) ,_, CHO_NP K1_NP ,_, CHO_NP alpha2_NN ,_, and_CC CHO_NP alpha2beta1_JJ cells_NNS bound_VBN Wa_NP at_IN similarly_RB low_JJ titers_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Thus_RB ,_, no_DT binding_NN of_IN Wa_NP to_TO human_JJ alpha2beta1_JJ or_CC human_JJ alpha2_NN dimerized_VBN with_IN hamster_NN beta1_NN was_VBD detected_VBN using_VBG integrin-transfected_JJ CHO_NP cells_NNS ._SENT MAbs_NP HAS4_NP and_CC HAS3_NP (_( data_NN not_RB shown_VBN )_) had_VBD no_DT effect_NN on_IN SA11_JJ infectivity_NN in_IN MA104_NP cells_NNS ._SENT In_IN contrast_NN ,_, MAb_NP AK7_NP inhibited_VBD SA11_JJ infectivity_NN in_IN a_DT dose-dependent_JJ fashion_NN ,_, as_RB reported_VBD previously_RB ._SENT According_VBG to_TO the_DT results_NNS of_IN flow_NN cytometry_NN ,_, the_DT major_JJ histocompatibility_NN complex_NN (_( MHC_NP )_) class_NN I-specific_NP MAb_NP W6/32_NP ,_, which_WDT has_VBZ been_VBN used_VBN previously_RB as_IN a_DT negative_JJ control_NN for_IN anti-alpha2_JJ MAb_NP blockade_NN of_IN echovirus_NN 1_CD cell_NN binding_NN ,_, bound_VBN 99.5_CD %_NN of_IN MA104_NP cells_NNS with_IN an_DT MFI_NP of_IN 20.1_CD +-_NN 0.5_CD ,_, but_CC this_DT binding_NN did_VBD not_RB affect_VB SA11_JJ infectivity_NN ,_, further_RBR demonstrating_VBG the_DT specificity_NN of_IN the_DT inhibition_NN by_IN MAb_NP AK7_NP ._SENT W6/32_NP also_RB had_VBD no_DT effect_NN on_IN the_DT infectivity_NN of_IN RRV_NP and_CC Wa_NP (_( data_NN not_RB shown_VBN )_) ._SENT Thus_RB ,_, the_DT interaction_NN of_IN SA11_NP with_IN monkey_NN alpha2beta1_NN on_IN MA104_NP cells_NNS is_VBZ specific_JJ for_IN alpha2_NN and_CC involves_VBZ the_DT alpha2_JJ I_NP domain_NN ._SENT A_DT compari_NN 